Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 5.98
+0.25 (4.36%)
Oct 21, 2026, 2:44 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 6.32 billion as of October 20, 2026. It is the 11,376th most valuable company in the world and the 544th biggest in Hong Kong. Its market cap has decreased by 32.30% in one year.
Market Cap
6.32B
Enterprise Value
3.70B
Revenue
1.09M
Global Rank
Country Rank
#544 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 6.32B, a decrease of -59.74%. That is a compound annual growth rate of -10.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 6.32B | -43.80% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 8.06B |
| Shaanxi Micot Pharmaceutical Technology | 7.96B |
| CStone Pharmaceuticals | 7.91B |
| Shanghai Haohai Biological Technology | 7.18B |
| Alphamab Oncology | 6.68B |
| CARsgen Therapeutics Holdings | 6.56B |
| Lepu Biopharma | 6.35B |
| LongBio Pharma (Suzhou) | 5.68B |